Target OAB drug received | Treatment status | Age, years | |||||
---|---|---|---|---|---|---|---|
Mirabegron (N = 1169)b | Antimuscarinics (N = 629) | Naïve (N = 1289) | Experienced (N = 509)b | 45–64 (N = 649) | 65–74 (N = 595) | ≥75 (N = 554)b | |
TTD | |||||||
Median, days | 90 | 56 | 60 | 99 | 60 | 90 | 91 |
(95% CI) | 90–92 | 30–56 | 60–61 | 92–121 | 56–60 | 68–91 | 90–99 |
HR (95% CI) | – | 1.52 (1.37–1.70)c | 1.35 (1.20–1.53)c | – | 1.53 (1.35–1.74)c | 1.15 (1.01–1.31)d | – |